Zimmer Nabs Bone Filler Product Maker ETEX Holdings

October 3, 2014

Orthopedic devicemaker Zimmer said Thursday it has acquired ETEX Holdings, a Cambridge, Mass.-based maker of bone void filler products. The deal — which is effective immediately — adds the Beta-bsm injectable, CarriGen, EquivaBone and Gamma-bsm putty to Zimmer’s biologics portfolio.

The move is part of Zimmer’s commitment to developing the most comprehensive range of biologic therapies for patients suffering from musculoskeletal joint disease, according to President Joseph A. Cucolo. He said ETEX's bone substitute materials add more depth to Zimmer’s portfolio of joint disease solutions.

ETEX focuses on expanding applications through combinations with cells, biologics or therapeutic agents delivered in minimally invasive and easy to use systems. The company’s proprietary biomimetic calcium phosphate technology mimics the chemical and structural features of human bone and promotes bone regeneration.

Terms of the transaction weren’t disclosed. — Kellen Owings

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.